A contribution from one of our readers:-
Apparently it’s not only the cost of doctors and hospitals, but medications too. We heard once from some one who makes a study of these things, that pills that sell for $1,200 each in the US can be bought for $5 in India.
Apparently, the Pharmaceutical Industry in the US (called “Big Pharma,”) is notorious for two things – the extent to which it is money hungry, and the extent to which it has influence amongst Governments.
These things are relevant when it comes to looking at the history of Low Dose Naltrexone – it’s a real oddity.
It’s said that Naltrexone was first made in 1965 and approved for medical use in 1984 – but at 50 mg daily, to treat people who had heroin addiction. But from about that time on, a Dr Bernard Bihari commenced making his pioneering discoveries that smaller doses of Naltrexone, almost certainly no higher than 4.5 mg, were amazingly successful in treating a broad scope of serious diseases.
To quote David Gluck:-
So as someone else has said, “Naltrexone is old, out of patent and low cost, so LDN won’t be produced/marketed by big Pharma. They focus on new, patented, expensive medicines.”